Literature DB >> 20097565

Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporter.

Kentaro Takada1, Nobutaka Imamura, Kirk R Gustafson, Curtis J Henrich.   

Abstract

In previous work, botryllamides discovered from the marine ascidian Botryllus tyreus were characterized as selective inhibitors of the ABCG2 multidrug transporter. However, the structural basis for this activity could not be established. In this study, botryllamide F, the core botryllamide structure, and botryllamide G, the most potent botryllamide ABCG2 inhibitor, were synthesized along with a series of structural variants for evaluation of structure-activity relationships. The biological activity of synthetic botryllamide analogs implied that the 2-methoxy-p-coumaric acid portion, and the degree of double bond conjugation within this group, were critical for inhibition of ABCG2. However, variations in the substituents on the two aryl groups did not appear to significantly impact the potency or degree of inhibition. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097565      PMCID: PMC2848298          DOI: 10.1016/j.bmcl.2010.01.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions.

Authors:  Anna Maria Calcagno; In-Wha Kim; Chung-Pu Wu; Suneet Shukla; Suresh V Ambudkar
Journal:  Curr Drug Deliv       Date:  2007-10       Impact factor: 2.565

2.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

Authors:  Johan W Jonker; Marije Buitelaar; Els Wagenaar; Martin A Van Der Valk; George L Scheffer; Rik J Scheper; Torsten Plosch; Folkert Kuipers; Ronald P J Oude Elferink; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

3.  Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin.

Authors:  Wanida Chearwae; Suneet Shukla; Pornngarm Limtrakul; Suresh V Ambudkar
Journal:  Mol Cancer Ther       Date:  2006-08       Impact factor: 6.261

4.  Total syntheses of (+/-)-anchinopeptolide D and (+/-)-cycloanchinopeptolide D.

Authors:  B B Snider; F Song; B M Foxman
Journal:  J Org Chem       Date:  2000-02-11       Impact factor: 4.354

Review 5.  Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates.

Authors:  Michael Dean; Tarmo Annilo
Journal:  Annu Rev Genomics Hum Genet       Date:  2005       Impact factor: 8.929

Review 6.  ABCG2: determining its relevance in clinical drug resistance.

Authors:  Robert W Robey; Orsolya Polgar; John Deeken; Kin Wah To; Susan E Bates
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

7.  Total synthesis of dictyodendrin B.

Authors:  Alois Fürstner; Mathias M Domostoj; Bodo Scheiper
Journal:  J Am Chem Soc       Date:  2005-08-24       Impact factor: 15.419

Review 8.  ABCG2 (BCRP) expression in normal and malignant hematopoietic cells.

Authors:  Brian L Abbott
Journal:  Hematol Oncol       Date:  2003-09       Impact factor: 5.271

9.  A high-throughput cell-based assay for inhibitors of ABCG2 activity.

Authors:  Curtis J Henrich; Heidi R Bokesch; Michael Dean; Susan E Bates; Robert W Robey; Ekaterina I Goncharova; Jennifer A Wilson; James B McMahon
Journal:  J Biomol Screen       Date:  2006-02-20

10.  Botryllamides: natural product inhibitors of ABCG2.

Authors:  Curtis J Henrich; Robert W Robey; Kentaro Takada; Heidi R Bokesch; Susan E Bates; Suneet Shukla; Suresh V Ambudkar; James B McMahon; Kirk R Gustafson
Journal:  ACS Chem Biol       Date:  2009-08-21       Impact factor: 5.100

  10 in total
  4 in total

Review 1.  Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin.

Authors:  Manickam Sugumaran; William E Robinson
Journal:  Mar Drugs       Date:  2010-12-06       Impact factor: 5.118

Review 2.  Marine natural products as breast cancer resistance protein inhibitors.

Authors:  Lilia Cherigo; Dioxelis Lopez; Sergio Martinez-Luis
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

3.  Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.

Authors:  Jonathan D Strope; Cody J Peer; Tristan M Sissung; O Morgan Hall; Phoebe A Huang; Emily M Harris; Kirk R Gustafson; Curtis J Henrich; Dina M Sigano; Gary T Pauly; Joel P Schneider; Susan E Bates; William D Figg
Journal:  Cancer Biol Ther       Date:  2019-11-10       Impact factor: 4.742

Review 4.  Ascidian Toxins with Potential for Drug Development.

Authors:  Dianne J Watters
Journal:  Mar Drugs       Date:  2018-05-13       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.